Lapatinib, a Dual Inhibitor of Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2, Potentiates the Antitumor Effects of Cisplatin on Esophageal Carcinoma
Type
Retraction
Notice date
11/1/2014 0:00
Journal
Diseases of the Esophagus: Official Journal of the International Society for Diseases of the Esophagus (ISDE)